(IN BRIEF) Sandoz has launched Afqlir®, its biosimilar to aflibercept, across Europe following European Commission approval in 2024. Equivalent in efficacy, safety, and pharmacokinetics to Eylea®, Afqlir® provides a lower-cost treatment option for serious retinal diseases such as nAMD, RVO, … Read the full press release
Posted in Business, Healthcare, Marketing, News, Pharma & Biotech, Switzerland
Tagged aflibercept, Afqlir, anti-VEGF market, biologic medicines, biosimilar portfolio, biosimilars, Christophe Delenta, DME, European Commission approval, European Rollout of Afqlir Marks Major Step in Sandoz Expansion Across Anti-VEGF Ophthalmology Market, Eylea, intravitreal injection, mCNV, nAMD, ophthalmology, retinal diseases, RVO, Sandoz, Sustainable Healthcare, vision loss treatment
(IN BRIEF) Roche has announced new data at the Euretina Congress in Paris from its AVONELLE-X and SALWEEN studies of Vabysmo (faricimab), confirming the therapy’s strong long-term outcomes for patients with retinal diseases. The AVONELLE-X study, the largest long-term extension … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged AVONELLE-X, bispecific antibody, diabetic macular edema, DME, durability, Euretina Congress, extended dosing, faricimab, Levi Garraway, long-term efficacy, LUCERNE, nAMD, neovascular age-related macular degeneration, ophthalmology, PCV, polypoidal choroidal vasculopathy, retinal vein occlusion, Roche, RVO, SALWEEN, TENAYA, Vabysmo, vision loss
(IN BRIEF) The CET Partnership’s 2025 call offers €2 million for international research projects that accelerate the EU’s energy transition toward a low-emission economy by 2050. Dutch applicants—including TO2 institutes—can apply for up to €400 000 per project, in collaboration … Read the full press release
Posted in Business, Energy, Gas & Oil, Environment, Financial, Government, Industrial, Infrastructure & Utilities, Investment, Management, Netherlands, News, Science, Technology
Tagged CET Partnership, Clean Energy Transition Partnership, European Climate Law, European Green Deal, Horizon Europe, hydrogen, industrial frameworks, integrated energy systems, international collaboration, low-emission economy 2050, matchmaking 19 June, matchmaking 24 June, multi-vector interactions, NWO, pre-proposal deadline 9 October 2025, renewable fuels, RVO, TO2 institutes, webinar 17 June, €2 million funding
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?